Clinical Practice Guidelines
3.0.0-ballot - STU 3 Ballot International flag

Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 3.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions

ActivityDefinition: CKD Referral Nephrology (Experimental)

Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-nephrology Version: 3.0.0-ballot
Standards status: Informative Computable Name: ReferralNephrology
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.11.21

Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

Metadata
Version 3.0.0-ballot
Identifier urn:oid:2.16.840.1.113883.4.642.40.48.11.21
Experimental true
Jurisdiction World
Steward (Publisher) HL7 International / Clinical Decision Support
Steward Contact HL7 International / Clinical Decision Support
Description

Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

Resource Kind ServiceRequest
Code Referral to nephrologist
Intent Proposal
Timing Events: ??
Citations and References
Justification Description: Refer to nephrologist for co-management of treatment plan in cases of: Unclear etiology of kidney disease Rapid progression of disease (GFR decline greater than 5 mL/minute/1.73 m²/year) Acute kidney injury or abrupt sustained fall in GFR GFR less than 30 mL/minute/1.73 m² (GFR categories G4-G5) to prepare for renal replacement therapy Consistent finding of significant albuminuria (albumin/creatinine ratio of 300 mg/g or more) Hypertension resistant to treatment with 4 or more antihypertensive agents Difficulty in decreasing the level of albuminuria despite institution of ACE inhibitor or angiotensin II receptor blocker therapy Persistent electrolyte abnormalities, including hyperkalemia or high serum phosphate Recurrent or extensive nephrolithiasis Hereditary kidney disease   Nephrologist involvement is recommended when the cause of chronic kidney disease is not clear Renal biopsy may be performed to determine the cause as well as to predict disease progression and response to therapy
Citation:

Elsevier. Chronic Kidney Disease Clinical Overview. ClinicalKey.

Content URL: https://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325
Document: text/html @ https://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325
Generated using version 0.5.6 of the sample-content-ig Liquid templates